ArticleLaboratory medicine2026
Analytical discrepancy in platelet counting in MYH9-related disease: a case report.
Article in Laboratory medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionMYH9-related disease (MYH9-RD) is a rare autosomal dominant disorder characterized by congenital macrothrombocytopenia, with giant platelets and variable extrahematologic manifestations. It is frequently underdiagnosed and misclassified as immune thrombocytopenia.
methodsA 31-year-old pregnant woman undergoing routine first-trimester testing was shown to have severe thrombocytopenia (platelet count = 5.000 × 10³/µL) by impedance counting.
resultsPlatelet histograms and scattergrams generated on a Sysmex XN-10 hematology analyzer suggested giant platelets, while fluorescence counting using a Sysmex XN-20 hematology analyzer yielded a higher platelet count (19.000 × 10³/µL), considered a more plausible estimate in the presence of giant platelets. Peripheral blood smear examination excluded platelet clumping and demonstrated numerous giant platelets and basophilic neutrophilic inclusions, subsequently interpreted as Döhle-like bodies. Further medical history revealed a previous diagnosis of MYH9-RD. Longitudinal evaluation showed persistently low but stable platelet counts, no kidney involvement, and mild liver enzyme elevation. DISCUSSION: This case highlights the diagnostic value of integrating automated hematology data with peripheral blood smear examination in inherited macrothrombocytopenias. Platelet counts in the presence of giant platelets may be underestimated by impedance-based analyzers because of size-dependent misclassification, whereas fluorescence-based counting may provide a more reliable estimate. Recognition of characteristic morphologic features, including Döhle-like bodies, is essential for identifying MYH9-RD and distinguishing it from immune thrombocytopenia, thereby avoiding inappropriate diagnostic and therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.